These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 30268919)

  • 41. Nosocomial outbreak of KPC-2- and NDM-1-producing Klebsiella pneumoniae in a neonatal ward: a retrospective study.
    Yu J; Tan K; Rong Z; Wang Y; Chen Z; Zhu X; Wu L; Tan L; Xiong W; Sun Z; Chen L
    BMC Infect Dis; 2016 Oct; 16(1):563. PubMed ID: 27733128
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Microbiological and molecular characteristics of carbapenemase-producing Klebsiella pneumoniae endemic in a tertiary Greek hospital during 2004-2010.
    Zagorianou A; Sianou E; Iosifidis E; Dimou V; Protonotariou E; Miyakis S; Roilides E; Sofianou D
    Euro Surveill; 2012 Feb; 17(7):. PubMed ID: 22370015
    [TBL] [Abstract][Full Text] [Related]  

  • 43. KPC-Producing Klebsiella pneumoniae Isolates in Croatia: A Nationwide Survey.
    Jelic M; Butic I; Plecko V; Cipris I; Jajic I; Bejuk D; Koscak I; Marinkovic S; Pal MP; Andrasevic AT
    Microb Drug Resist; 2016 Dec; 22(8):662-667. PubMed ID: 26709956
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Whole genome sequencing for the molecular characterization of carbapenem-resistant Klebsiella pneumoniae strains isolated at the Italian ASST Fatebenefratelli Sacco Hospital, 2012-2014.
    Rimoldi SG; Gentile B; Pagani C; Di Gregorio A; Anselmo A; Palozzi AM; Fortunato A; Pittiglio V; Ridolfo AL; Gismondo MR; Rizzardini G; Lista F
    BMC Infect Dis; 2017 Oct; 17(1):666. PubMed ID: 29017452
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Complex prosthetic joint infections due to carbapenemase-producing Klebsiella pneumoniae: a unique challenge in the era of untreatable infections.
    de Sanctis J; Teixeira L; van Duin D; Odio C; Hall G; Tomford JW; Perez F; Rudin SD; Bonomo RA; Barsoum WK; Joyce M; Krebs V; Schmitt S
    Int J Infect Dis; 2014 Aug; 25():73-8. PubMed ID: 24813874
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Epidemiology of Carbapenem-Resistant Klebsiella pneumoniae Bloodstream Infections in a Chinese Children's Hospital: Predominance of New Delhi Metallo-β-Lactamase-1.
    Dong F; Zhang Y; Yao K; Lu J; Guo L; Lyu S; Yang Y; Wang Y; Zheng H; Song W; Liu G
    Microb Drug Resist; 2018 Mar; 24(2):154-160. PubMed ID: 28594635
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Outbreak of carbapenem-resistant Klebsiella pneumoniae in Puerto Rico associated with a novel carbapenemase variant.
    Gregory CJ; Llata E; Stine N; Gould C; Santiago LM; Vazquez GJ; Robledo IE; Srinivasan A; Goering RV; Tomashek KM
    Infect Control Hosp Epidemiol; 2010 May; 31(5):476-84. PubMed ID: 20334553
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Genetic characterisation of clinical Klebsiella pneumoniae isolates with reduced susceptibility to tigecycline: Role of the global regulator RamA and its local repressor RamR.
    Wang X; Chen H; Zhang Y; Wang Q; Zhao C; Li H; He W; Zhang F; Wang Z; Li S; Wang H
    Int J Antimicrob Agents; 2015 Jun; 45(6):635-40. PubMed ID: 25681067
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A 4.5-Year Within-Patient Evolution of a Colistin-Resistant Klebsiella pneumoniae Carbapenemase-Producing K. pneumoniae Sequence Type 258.
    Jousset AB; Bonnin RA; Rosinski-Chupin I; Girlich D; Cuzon G; Cabanel N; Frech H; Farfour E; Dortet L; Glaser P; Naas T
    Clin Infect Dis; 2018 Oct; 67(9):1388-1394. PubMed ID: 29688339
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Dissemination of Klebsiella pneumoniae ST11 isolates with carbapenem resistance in integrated and emergency intensive care units in a Chinese tertiary hospital.
    Yu F; Hu L; Zhong Q; Hang Y; Liu Y; Hu X; Ding H; Chen Y; Xu X; Fang X; Yu F
    J Med Microbiol; 2019 Jun; 68(6):882-889. PubMed ID: 31050634
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Clonal replacement of epidemic KPC-producing Klebsiella pneumoniae in a hospital in China.
    Liang Y; Yin X; Zeng L; Chen S
    BMC Infect Dis; 2017 May; 17(1):363. PubMed ID: 28535790
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Colistin-sparing regimens against Klebsiella pneumoniae carbapenemase-producing K. pneumoniae isolates: Combination of tigecycline or doxycycline and gentamicin or amikacin.
    Tang HJ; Lai CC; Chen CC; Zhang CC; Weng TC; Chiu YH; Toh HS; Chiang SR; Yu WL; Ko WC; Chuang YC
    J Microbiol Immunol Infect; 2019 Apr; 52(2):273-281. PubMed ID: 27133391
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Multidrug Resistance Mechanisms of Carbapenem Resistant Klebsiella pneumoniae Strains Isolated in Chongqing, China.
    Yan J; Pu S; Jia X; Xu X; Yang S; Shi J; Sun S; Zhang L
    Ann Lab Med; 2017 Sep; 37(5):398-407. PubMed ID: 28643488
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Carbapenem resistant Klebsiella pneumoniae isolated from bloodstream infection: Indian experience.
    Veeraraghavan B; Shankar C; Karunasree S; Kumari S; Ravi R; Ralph R
    Pathog Glob Health; 2017 Jul; 111(5):240-246. PubMed ID: 28670975
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Emergence of clonally related Klebsiella pneumoniae isolates of sequence type 258 producing plasmid-mediated KPC carbapenemase in Norway and Sweden.
    Samuelsen Ø; Naseer U; Tofteland S; Skutlaberg DH; Onken A; Hjetland R; Sundsfjord A; Giske CG
    J Antimicrob Chemother; 2009 Apr; 63(4):654-8. PubMed ID: 19218573
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Performance of VITEK 2, E-test, Kirby-Bauer disk diffusion, and modified Kirby-Bauer disk diffusion compared to reference broth microdilution for testing tigecycline susceptibility of carbapenem-resistant K. pneumoniae and A. baumannii in a multicenter study in China.
    Yin D; Guo Y; Li M; Wu W; Tang J; Liu Y; Chen F; Ni Y; Sun J; Zhang H; Zhao H; Hu F
    Eur J Clin Microbiol Infect Dis; 2021 Jun; 40(6):1149-1154. PubMed ID: 33411173
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Reversion to susceptibility of a carbapenem-resistant clinical isolate of Klebsiella pneumoniae producing KPC-3.
    Villa L; Capone A; Fortini D; Dolejska M; Rodríguez I; Taglietti F; De Paolis P; Petrosillo N; Carattoli A
    J Antimicrob Chemother; 2013 Nov; 68(11):2482-6. PubMed ID: 23800906
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Molecular characterization of novel sequence type of carbapenem-resistant New Delhi metallo-β-lactamase-1-producing Klebsiella pneumoniae in the neonatal intensive care unit of an Indian hospital.
    Ahmad N; Ali SM; Khan AU
    Int J Antimicrob Agents; 2019 Apr; 53(4):525-529. PubMed ID: 30578964
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The emergence of bla
    Moghadampour M; Rezaei A; Faghri J
    Acta Microbiol Immunol Hung; 2018 Aug; 65(3):335-344. PubMed ID: 30024268
    [TBL] [Abstract][Full Text] [Related]  

  • 60. First report of NDM-1-producing Klebsiella pneumoniae imported from Africa to Italy: Evidence of the need for continuous surveillance.
    Principe L; Mauri C; Conte V; Pini B; Giani T; Rossolini GM; Luzzaro F
    J Glob Antimicrob Resist; 2017 Mar; 8():23-27. PubMed ID: 27939808
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.